XML 54 R47.htm IDEA: XBRL DOCUMENT
v3.26.1

Collaboration Revenue - Additional Information (Details) $ in Thousands | 6 Months Ended
--- | ---
Jun. 30, 2025 USD ($)
Neurocrine Biosciences [Member] | License and Collaboration Agreement [Member] |
Collaborative Arrangements and Non-collaborative Arrangement Transactions [Line Items] |
Milestone revenue | $ 7,500

X
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 808 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (d) -Publisher FASB -URI https://asc.fasb.org/1943274/2147479402/808-10-50-1 + Details
Name: | us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Milestone revenue + References No definition available. + Details
Name: | xene_MilestoneRevenue
Namespace Prefix: | xene_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Details
Name: | srt_CounterpartyNameAxis=xene_NeurocrineBiosciencesMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_TypeOfArrangementAxis=xene_LicenseAndCollaborationAgreementMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |